NCT06941844
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT06941844
- Registry
- ClinicalTrials.gov
- NCT number
- NCT06941844
- Sponsor, as registered
- Definium Therapeutics US, Inc.
- Phase
- PHASE3
- Indication
- Major Depressive Disorder
- Status
- ACTIVE_NOT_RECRUITING
- Start date
- 2025-04-14
- Primary completion
- 2026-05-20
- Registered countries
- United States
- Sites
- 22
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-08-31
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country.
Company
Through DT120 (registry title MM120): Definium Therapeutics
Cited in
Issues quoting NCT06941844 in their own text.